Haemonetics
HAE
Source: the SEC Form 13F filings of the managers we follow, latest for Q2 2026. How we use them
Value held
$155m
Combined value at quarter end
Last quarter
1 bought
0 sold or trimmed
Managers holding it, by quarter
0Q4 ’23
1Q1 ’24
0Q2 ’24
0Q3 ’24
0Q4 ’24
0Q1 ’25
0Q2 ’25
0Q3 ’25
0Q4 ’25
0Q1 ’26
1Q2 ’26
0Q3 ’26
Who holds it
| Ariel Investments | 1.5%$155m | New |
About the company
- Sector
- Health care · Surgical & Medical Instruments & Apparatus
- Incorporated in
- Massachusetts
- Financial year ends
- 3 April
- Shares outstanding
- 45m at 31 Jul 2026
- SEC filings
- Annual reports and other filings on EDGAR
Revenue and profit
$939mMar ’14
Apr ’16
Mar ’18
Mar ’20
$993mApr ’22
$1.3bnMar ’24
$1.3bnMar ’26
| Year | Revenue | Net income |
|---|---|---|
| Year to Mar 2026 | $1.3bn | $97k |
| Year to Mar 2025 | $1.4bn | $168k |
| Year to Mar 2024 | $1.3bn | $118m |
| Year to Apr 2023 | $1.2bn | $115m |
| Year to Apr 2022 | $993m | $43.4m |
| Year to Apr 2021 | – | $79.5m |
| Year to Mar 2020 | – | $76.5m |
| Year to Mar 2019 | – | $55.0m |
| Year to Mar 2018 | – | $45.6m |
| Year to Apr 2017 | – | −$26.3m |
| Year to Apr 2016 | – | −$55.6m |
| Year to Mar 2015 | $910m | $16.9m |
| Year to Mar 2014 | $939m | $35.1m |